Seroatlas · Human Serome Atlas

SUMO2

Small ubiquitin-related modifier 2

Also known as: SMT3B, SMT3H2, SUMO2_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P61956
Gene
SUMO2
Ensembl
ENSG00000188612
Chromosome
17
Canonical length
95 aa
Protein class
Predicted intracellular proteins
Subcellular location
Nucleoplasm,Nuclear bodies,Calyx,Connecting piece,Flagellar centriole

OverviewNCBI Gene

This gene encodes a protein that is a member of the SUMO (small ubiquitin-like modifier) protein family. It functions in a manner similar to ubiquitin in that it is bound to target proteins as part of a post-translational modification system. However, unlike ubiquitin which targets proteins for degradation, this protein is involved in a variety of cellular processes, such as nuclear transport, transcriptional regulation, apoptosis, and protein stability. It is not active until the last two amino acids of the carboxy-terminus have been cleaved off. Numerous pseudogenes have been reported for this gene. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

95 residues, UniProt reviewed canonical sequence.

>P61956|SUMO2
     1  MADEKPKEGV KTENNDHINL KVAGQDGSVV QFKIKRHTPL SKLMKAYCER QGLSMRQIRF
    61  RFDGQPINET DTPAQLEMED EDTIDVFQQQ TGGVY

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against SUMO2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.41
Highest tissue expression
288 nTPM

Expression across tissuesHPA

Tissue

  • cerebellum: 288 nTPM
  • ovary: 269 nTPM
  • thymus: 253 nTPM
  • esophagus: 223 nTPM
  • bone marrow: 217 nTPM
  • skeletal muscle: 215 nTPM

Single-cell type

  • late spermatids: 394 nCPM
  • late primary spermatocytes: 279 nCPM
  • esophageal apical cells: 202 nCPM
  • parietal cells: 157 nCPM
  • oocytes: 147 nCPM
  • early spermatids: 132 nCPM

Immune cell

  • total PBMC: 853 nTPM
  • basophil: 834 nTPM
  • eosinophil: 784 nTPM
  • T-reg: 704 nTPM
  • plasmacytoid DC: 618 nTPM
  • non-classical monocyte: 551 nTPM

Brain region

  • cerebellum: 217 nTPM
  • hypothalamus: 175 nTPM
  • white matter: 167 nTPM
  • cerebral cortex: 166 nTPM
  • spinal cord: 163 nTPM
  • basal ganglia: 158 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.45
gnomAD pLI
0.87
gnomAD missense Z
2.2

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of SUMO2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads SUMO2 as an antibody target. Whether an autoantibody or antibody against SUMO2 could matter depends on whether native SUMO2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

SUMO2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label SUMO2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/SUMO2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...